Tag: ACR 2025
-
Multiple Innovent Biomedicine Pipeline Results Highlight at 2025 ACR Annual Meeting
Overview: Innovent showcases General Biomedicine Pipeline at the 2025 ACR Annual Meeting Innovent Biologics, a global biopharmaceutical leader, presented multiple research results from its General Biomedicine Pipeline at the 2025 American College of Rheumatology (ACR) Annual Meeting and related events. While the conference is renowned for rheumatology and autoimmune disease breakthroughs, Innovent emphasized its expanding…
-
Innovent Highlights Broad Biomedicine Pipeline at 2025 ACR Annual Meeting
Innovent Showcases Broad Biomedicine Pipeline at 2025 ACR Annual Meeting Innovent Biologics, a leading biopharmaceutical company focused on developing, manufacturing, and commercializing high-quality medicines, today highlighted multiple research results from its general biomedicine pipeline at the 2025 American College of Rheumatology (ACR) Annual Meeting. The event, held in San Francisco with contributions from Innovent’s teams…
-
Innovent Highlights: General Biomedicine Pipeline Showcased at 2025 ACR Annual Meeting
Innovent Unveils Progress Across the General Biomedicine Pipeline at the 2025 ACR Annual Meeting The 2025 ACR Annual Meeting in San Francisco and nearby venues became a hub for researchers and industry leaders as Innovent Biologics, a global biopharmaceutical company, highlighted several milestones from its General Biomedicine Pipeline. The presentations underscored a commitment to advancing…